These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 24338161)

  • 1. Using existing data to identify candidate items for a health state classification system in multiple sclerosis.
    Kuspinar A; Finch L; Pickard S; Mayo NE
    Qual Life Res; 2014 Jun; 23(5):1445-57. PubMed ID: 24338161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of the psychometric properties of generic utility measures in multiple sclerosis.
    Kuspinar A; Mayo NE
    Pharmacoeconomics; 2014 Aug; 32(8):759-73. PubMed ID: 24846760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do generic utility measures capture what is important to the quality of life of people with multiple sclerosis?
    Kuspinar A; Mayo NE
    Health Qual Life Outcomes; 2013 Apr; 11():71. PubMed ID: 23618072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Scoring Algorithm for Deriving Utility Values from the Neuro-QoL for Patients with Multiple Sclerosis.
    Matza LS; Phillips G; Dewitt B; Stewart KD; Cella D; Feeny D; Hanmer J; Miller DM; Revicki DA
    Med Decis Making; 2020 Oct; 40(7):897-911. PubMed ID: 33016238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of generic and condition-specific measures of health-related quality of life in NICE decision-making: a systematic review, statistical modelling and survey.
    Longworth L; Yang Y; Young T; Mulhern B; Hernández Alava M; Mukuria C; Rowen D; Tosh J; Tsuchiya A; Evans P; Devianee Keetharuth A; Brazier J
    Health Technol Assess; 2014 Feb; 18(9):1-224. PubMed ID: 24524660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimating a Preference-Based Index for an Eight-Dimensional Health State Classification System for Multiple Sclerosis.
    Goodwin E; Green C; Spencer A
    Value Health; 2015 Dec; 18(8):1025-36. PubMed ID: 26686787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the preference-based multiple sclerosis index.
    Kuspinar A; Mayo NE
    Mult Scler; 2019 Oct; 25(11):1496-1505. PubMed ID: 30070613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative performance analysis of the International Classification of Functioning, Disability and Health and the Item-Perspective Classification framework for classifying the content of patient reported outcome measures.
    Rosa D; MacDermid J; Klubowicz D
    Health Qual Life Outcomes; 2021 Apr; 19(1):132. PubMed ID: 33892735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using the Fatigue Severity Scale to inform healthcare decision-making in multiple sclerosis: mapping to three quality-adjusted life-year measures (EQ-5D-3L, SF-6D, MSIS-8D).
    Goodwin E; Hawton A; Green C
    Health Qual Life Outcomes; 2019 Aug; 17(1):136. PubMed ID: 31382960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Quality-Adjusted Life-Year Measure for Multiple Sclerosis: Developing a Patient-Reported Health State Classification System for a Multiple Sclerosis-Specific Preference-Based Measure.
    Goodwin E; Green C
    Value Health; 2015 Dec; 18(8):1016-24. PubMed ID: 26686786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of disease severity on EQ-5D and SF-6D utility discrepancies in chronic heart failure.
    Kontodimopoulos N; Argiriou M; Theakos N; Niakas D
    Eur J Health Econ; 2011 Aug; 12(4):383-91. PubMed ID: 20473544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using the Multiple Sclerosis Impact Scale to estimate health state utility values: mapping from the MSIS-29, version 2, to the EQ-5D and the SF-6D.
    Hawton A; Green C; Telford C; Zajicek J; Wright D
    Value Health; 2012 Dec; 15(8):1084-91. PubMed ID: 23244811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Preference-Based Multiple Sclerosis Index: an assessment of its psychometric properties and translation into Turkish.
    Kahraman T; Ozdogar AT; Abasiyanik Z; Sagici O; Baba C; Ertekin O; Ozakbas S
    Disabil Rehabil; 2023 Apr; 45(8):1412-1418. PubMed ID: 35387534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rasch analysis of a new stroke-specific outcome scale: the Stroke Impact Scale.
    Duncan PW; Bode RK; Min Lai S; Perera S;
    Arch Phys Med Rehabil; 2003 Jul; 84(7):950-63. PubMed ID: 12881816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping ALSFRS-R and ALSUI to EQ-5D in Patients with Motor Neuron Disease.
    Moore A; Young CA; Hughes DA
    Value Health; 2018 Nov; 21(11):1322-1329. PubMed ID: 30442280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health Utilities for Multiple Sclerosis.
    Hawton A; Green C
    Value Health; 2016 Jun; 19(4):460-8. PubMed ID: 27325338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mapping analyses to estimate EQ-5D utilities and responses based on Oxford Knee Score.
    Dakin H; Gray A; Murray D
    Qual Life Res; 2013 Apr; 22(3):683-94. PubMed ID: 22555470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health State Values Derived from People with Multiple Sclerosis for a Condition-Specific Preference-Based Measure: Multiple Sclerosis Impact Scale-Eight Dimensions-Patient Version (MSIS-8D-P).
    Goodwin E; Green C; Hawton A
    Value Health; 2018 Nov; 21(11):1338-1345. PubMed ID: 30442282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Getting the measure of spasticity in multiple sclerosis: the Multiple Sclerosis Spasticity Scale (MSSS-88).
    Hobart JC; Riazi A; Thompson AJ; Styles IM; Ingram W; Vickery PJ; Warner M; Fox PJ; Zajicek JP
    Brain; 2006 Jan; 129(Pt 1):224-34. PubMed ID: 16280352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developing and testing methods for deriving preference-based measures of health from condition-specific measures (and other patient-based measures of outcome).
    Brazier JE; Rowen D; Mavranezouli I; Tsuchiya A; Young T; Yang Y; Barkham M; Ibbotson R
    Health Technol Assess; 2012 Jul; 16(32):1-114. PubMed ID: 22832015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.